Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-31

FDA Approved: EPINASTINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved Somerset Therapeutics' epinastine hydrochloride as a generic product under an original ANDA for the treatment of allergic conjunctivitis. This …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinastine hydrochloride (epinastine hydrochloride)

Snippet

ORIG AP for EPINASTINE HYDROCHLORIDE (EPINASTINE HYDROCHLORIDE)